Biotech VC Funds

Illumina Ventures is an influential venture capital firm focused on advancing genomics and precision health. Established in partnership with Illumina, the firm targets early-stage companies driving innovation in life science tools, therapeutics, diagnostics, and personal wellness. Their notable investments include leading companies like 23andMe, Twist Bioscience, and Sherlock Biosciences. Illumina Ventures primarily operates within North America but maintains a global investment scope. The firm typically leads investment rounds, with a strong emphasis on startups harnessing cutting-edge technologies like AI, machine learning, and synthetic biology to improve human health. Recent investments highlight their commitment to transformative technologies, with companies such as Actym Therapeutics and Redshift Bio joining their portfolio. Key figures at Illumina Ventures include founding partner Nick Naclerio, who brings extensive experience from his tenure at Illumina Inc., and Malek Faham, promoted to Chief Scientist. The team is complemented by experts like Thomas Ybert of DNA Script, underscoring the firm's robust support for its portfolio companies.

Imec.xpand is a venture capital firm based in Leuven, Belgium, founded in 2017. The firm focuses on early-stage investments in deep-tech innovations, particularly those based on nanoelectronics. Their investment areas span health, agtech, and semiconductor technology, aiming to foster significant technological advancements and growth. Notable investments include PsiQuantum, a quantum computing company, and Axelera AI, a startup developing AI applications for edge computing. Other prominent portfolio companies are Spectricity, which specializes in hyperspectral sensing solutions, and Optalysys, an AI-driven big data and machine learning company. Imec.xpand typically leads funding rounds, with investment amounts averaging around $21 million per round. The firm has made 41 investments to date, with a robust global presence, investing in companies from the U.S., Europe, and beyond. Their strategic approach leverages their affiliation with Imec, a world-renowned R&D hub for nanoelectronics and digital technologies, providing startups with unparalleled access to cutting-edge research, expertise, and infrastructure​. Key team members include Tom Vanhoutte and Frank Bulens, who bring extensive experience in deep tech and venture capital, further solidifying Imec.xpand’s position as a leader in the tech investment space​.

IMO Ventures is a venture capital firm focusing on early-stage investments in technology, media, telecommunications (TMT), fintech, consumer, and healthcare industries. The firm is driven by a mission to support entrepreneurship and innovation, leveraging the extensive experience of its partners who were former tech entrepreneurs and industry leaders. The team at IMO Ventures includes Hai Liu, who has a background in electronic engineering and an MBA from MIT Sloan. He has previously worked with GSR Ventures and Samsung Mobile, bringing significant expertise to the firm​. IMO Ventures invests in startups that harness the power of computing and technology to drive change. They believe in supporting entrepreneurs from the ground up, providing not only financial backing but also strategic guidance and industry connections​. Their portfolio features a diverse range of companies, showcasing their commitment to fostering innovation across multiple sectors.

Impact America Fund (IAF) is a trailblazing venture capital firm dedicated to empowering marginalized communities through strategic investments in early-stage companies. Notable portfolio companies include Aja Labs, which innovates sustainable hair extension materials, and Mayvenn, a marketplace increasing income for independent hair stylists. Additionally, IAF has invested in Camino Financial, supporting Latinx-owned small businesses, and CareAcademy, which upskills home health caregivers. IAF focuses on industries that address systemic inequities, particularly within tech and consumer goods sectors, ensuring that economic participation and agency are accessible to people of color. Geographically, IAF targets the U.S., with a keen interest in underrepresented communities. The fund's strategy involves leading rounds and providing substantial support to its portfolio companies. With an average check size varying by stage, IAF is known for its hands-on approach, offering guidance beyond capital. The team prefers startups to approach them through their simple online form, emphasizing the importance of mission alignment. Founded by Kesha Cash, a seasoned investor with roots in both Wall Street and marginalized communities, IAF boasts a team with diverse expertise spanning tech, media, government, and law. Their latest $112 million fund aims to support 30 new companies, continuing their mission to uplift Black and Brown entrepreneurs and workers.

Impact Science Ventures is a venture capital firm based in San Francisco, California, focused on investing in scientific and technological innovations that address significant challenges in critical impact sectors, such as renewable energy, sustainability, and advanced materials. Founded in 2021, the firm emphasizes supporting early-stage companies that leverage breakthrough scientific research to create transformative solutions. The firm has a diverse portfolio, with investments spanning industries like alternative energy, energy infrastructure, and environmental services. Some of the notable companies in their portfolio include Antora Energy, known for its work in decarbonizing heavy industries, and Fervo Energy, which is pioneering next-generation geothermal energy solutions. Impact Science Ventures aims to be more than just a financial backer; they provide strategic support and resources to help these companies succeed commercially. Impact Science Ventures manages several funds, including their flagship Fund I, which is dedicated to early-stage investments. The firm is led by experienced professionals like Alain Harrus and Robert Ethier, who bring a wealth of knowledge in both venture capital and scientific research to their roles.

Impact46 is a leading venture capital firm based in Riyadh, Saudi Arabia, established in 2019. The firm focuses on early and growth-stage investments, particularly in the tech sector, and is one of the first VC firms to be authorized by Saudi Arabia's Capital Market Authority (CMA). Impact46 primarily invests in startups within Saudi Arabia but also targets promising opportunities across the MENA region. Key sectors include fintech, e-commerce, and SaaS. Their portfolio consists of notable startups like Jahez (a food delivery platform), Tamara (a buy-now-pay-later fintech company), and Syarah (an online automotive platform). Impact46’s investment in Jahez yielded a significant return, with the company going public in 2021 and offering a 22x return on investment. The firm’s strategy revolves around supporting local entrepreneurs with capital and strategic guidance to scale their businesses. They manage multiple funds, including a $133 million fund launched to continue supporting tech-driven startups across the region.

Imprimatur Capital is a venture capital firm with a strong focus on early-stage technology startups in the Baltic Sea region. Established in 2003, the firm has carved out a niche in sectors like B2B software, digital health, robotics, and automation. With a global perspective, Imprimatur helps startups with scalable business models reach international markets. The firm typically invests between €200k and €2 million in companies that have demonstrated initial revenue, particularly those with a minimum of €5,000 MRR. Imprimatur’s team operates from offices in Riga, London, and Singapore, bringing deep expertise in engineering, life sciences, entrepreneurship, and finance to the table. This diverse skill set enables the firm to provide more than just capital; they offer strategic guidance to ensure startups achieve sustainable growth. Imprimatur’s investment strategy is built on identifying ambitious founders with innovative solutions that address significant market needs. Their portfolio includes over 70 startups, such as Anatomy Next, which has successfully scaled with their support. Although their current fund is fully invested, Imprimatur continues to maintain a strong presence in the venture capital ecosystem, focusing on driving technological advancements that have the potential to impact industries globally. Their commitment to fostering innovation is evident in their active involvement in the startups they back, providing long-term support that goes beyond initial funding to include mentorship, market access, and business development expertise.

Incite.org, founded by Swati Mylavarapu and Matt Rogers, is a unique hybrid organization that combines venture capital, philanthropy, and civic advocacy to drive positive global change. Their mission is to support bold, innovative entrepreneurs and activists who are working on underfunded and crucial challenges, particularly in areas like climate change, social justice, and economic opportunity. Incite operates through three primary branches: Incite Ventures, which provides catalytic capital to mission-driven startups with the potential to scale and make a significant impact; Incite Labs, a nonprofit arm that funds charitable and educational initiatives through grants and program-related investments; and Incite Politics, which supports political initiatives and candidates that aim to disrupt the status quo and promote diverse leadership. The team at Incite is deeply committed to fostering long-term relationships with the founders and organizations they support, offering not just funding but also mentorship, strategic advice, and access to a wide network of resources. Their investment philosophy focuses on finding and nurturing ideas that have the potential to create significant, lasting change. This approach has positioned Incite as a powerful force in impact investing, enabling them to back ventures that are not just profitable but also socially and environmentally responsible​.

Incuba Venture is the investment arm of INCUBA, a leading science park and innovation hub based in Aarhus, Denmark. INCUBA houses 175 startups, spinouts, scaleups, and established companies represented by more than 1,800 employees, researchers, entrepreneurs, and specialists across approximately 60,000 square meters at four locations in the city. The organization operates in close collaboration with Aarhus University, Aarhus University Hospital, and other knowledge-intensive partners, and focuses on three key verticals: IT and tech at Katrinebjerg, cleantech at Navitas, and life science at Skejby. INCUBA Next, the newest facility, opened in October 2024. Incuba Venture makes early-stage pre-seed and seed investments in Danish companies across software, cleantech, health technology, biotech, and AI. CEO Jakob Doktor Morgensen is also involved with Delphinus Venture Capital, a new fund established by the Aarhus University Research Foundation, HEARTLAND, Norlys, and Salling Group to drive growth in the startup ecosystem across East and Central Jutland. The organization has an estimated 243 investments to date, reflecting its central position in the Danish early-stage ecosystem. Beyond capital, INCUBA serves as a growth driver for emerging companies by providing facilities, networking, business counselling, and research contacts. The organization also owns and organizes the Aarhus Investor Summit, an annual series of events bringing together angel investors, accelerators, and venture capitalists from Denmark and Europe with a shared interest in early-stage tech startups. This combination of infrastructure, services, and a collaborative network positions Incuba Venture as a distinctive hybrid of investor and ecosystem builder in the Nordic region.

Incubate Fund, established in 2010, is a leading early-stage venture capital firm based in Tokyo, Japan. The firm has a significant presence globally, with offices in key locations such as Singapore, Bangalore, Mumbai, São Paulo, and Mountain View. Known for its extensive portfolio, Incubate Fund has invested in over 300 companies and has facilitated numerous successful exits, including notable firms like Pixie Dust Technologies, Sansan, and WealthNavi. Incubate Fund Asia, a branch of the firm, recently announced the first close of its third fund with a target corpus of $50 million. This fund aims to support pre-seed and seed-stage startups across India and Southeast Asia, focusing on sectors such as B2B, B2C, supply chain, and consumer tech. Notable investments by Incubate Fund Asia include Captain Fresh, ShopKirana, and Yulu. The firm’s mission is to empower startups and fuel innovation across Asia. Incubate Fund provides financial support and strategic guidance to help startups achieve market leadership and sustainable growth

InCube Ventures is a life sciences venture capital firm founded in 2008 and based in San Jose, California, operating as the venture arm of InCube Labs, a research and development laboratory with facilities in Silicon Valley and San Antonio. The firm was founded by Mir Imran, one of the leading healthcare innovators who has founded more than 20 life sciences companies, 15 of which have achieved exits through acquisitions or IPOs. Managing Partners Andrew Farquharson and Wayne Roe lead the fund alongside Imran, with Farquharson holding a Kauffman Fellowship. The firm's earliest fund, DFJ InCube Ventures, was managed in partnership with Draper Fisher Jurvetson. InCube Ventures leads rounds and invests in extraordinary innovations that address unmet clinical needs for large patient populations, with typical deal sizes in the $10 to $50 million range across seed, Series A, and Series B. The portfolio of 18 companies spans pharma, biologics, and medical devices, covering clinical areas including atrial fibrillation, epilepsy, GI surgery, iron-deficiency anemia, hemorrhagic stroke, obesity, and metabolic disorders. Notable portfolio companies include Metagenomi Therapeutics, which completed its NASDAQ IPO in February 2024 at a $563 million market cap, and Rani Therapeutics, which listed on NASDAQ at a $528 million market cap. Channel Medsystems was acquired by Boston Scientific for $275 million in November 2017. The portfolio has produced 2 IPOs and 6 acquisitions in total. InCube Ventures draws a direct pipeline from InCube Labs, where some portfolio companies originate, while others are sourced externally. This structure gives the firm a differentiated ability to identify innovations at the earliest formation stage, well before they reach institutional markets. The team engages directly with clinical development processes and brings deep domain expertise spanning cardiology, oncology, neurology, and metabolic medicine to support founders through regulatory and commercial milestones.

Indaco Venture Partners SGR, established in 2016, is Italy's largest independent venture capital firm, managing over €350 million across six funds. Their investment strategy is centered on breakthrough innovations, focusing primarily on sectors like electronics, robotics, medtech, biotech, pharma, and digital technologies. Indaco is renowned for supporting startups with cutting-edge proprietary technologies, typically participating in seed to Series B rounds with investments starting from €3 million. The firm's geographic reach spans Europe, the U.S., and Israel, but its core focus remains on Italian enterprises. Their anchor investors include leading institutions like Intesa Sanpaolo, Fondazione Cariplo, and the European Investment Fund, underscoring their credibility in the European VC landscape. Indaco has also forged strategic partnerships in digital and biotech sectors, such as with growITup and Università di Milano, allowing them to leverage deep industry expertise. Led by co-founders Davide Turco, Elizabeth Robinson, and Antonella Beltrame, the team has a wealth of experience in venture capital and has achieved numerous successful exits, including IPOs and major corporate transactions. Indaco's diverse team brings backgrounds from private equity, science, and technology research, giving them a unique ability to identify high-potential startups. For founders, Indaco’s rigorous selection process favors companies that can demonstrate technological leadership and scalability, especially those looking to expand globally. Their track record of over 40 portfolio companies and more than 15 successful exits makes them a key player in fostering the next generation of innovative leaders.

Index Ventures is a renowned venture capital firm with dual headquarters in San Francisco and London. Founded in 1996, the firm has a strong track record of investing in transformative companies across various sectors including technology, fintech, healthcare, and consumer products. Notable investments by Index Ventures include some of the biggest names in tech and business today. These include Dropbox, Figma, Slack, Roblox, Adyen, and Deliveroo. The firm has been instrumental in the growth of these companies, providing both financial backing and strategic support​. Index Ventures has raised several significant funds to support its investment strategy. Recently, they closed $3.1 billion in new funds, which are spread across early-stage, growth-stage, and seed-stage investments. This substantial capital allows them to back innovative startups from inception through to maturity​. The firm is known for its deep commitment to the entrepreneurs they support, emphasizing close partnerships and long-term growth. This approach has made Index Ventures a preferred partner for visionary founders looking to scale their businesses globally​.

Indicator Ventures, founded in 2014, is an early-stage venture capital firm with offices in Boston and New York. The firm focuses on investing in technology companies that enhance digital health, enterprise automation, and financial technology. They emphasize the consumerization and accessibility of these sectors, aiming to support transformational companies from the pre-seed to seed stages. Notable investments by Indicator Ventures include Audioshake, BOND, and Unikrn, reflecting their commitment to supporting innovative tech solutions that streamline work, life, and wealth-building. They typically invest up to $2 million in new companies, often leading or co-leading funding rounds and partnering with other top seed-stage investors. Indicator Ventures values mission-driven, problem-obsessed founders with the ability to execute their vision effectively. Their investment strategy is hands-on, providing support in talent acquisition, company culture, and strategic guidance to help portfolio companies navigate challenges and scale successfully. They maintain a lean investment model, allowing them to dedicate significant time and resources to each portfolio company.

Indico Capital Partners, based in Lisbon, Portugal, focuses on early-stage technology and sustainability investments, especially in AI, SaaS, fintech, and the blue economy. Notable investments include Rows, FRVR, and Oceano Fresco. With over €194 million in assets under management across six funds, Indico plays an active role in scaling startups from Portugal and Spain to a global level. Indico typically leads rounds at the seed stage, investing between €100K to €5M per company, and often co-invests with larger firms like Accel. They also offer hands-on support through their Indico Founders Program, providing mentorship and access to their international network. Indico is particularly focused on companies with global ambitions, leveraging their team’s expertise and investor network to help scale ventures beyond local markets. The team includes co-founders Stephan Morais, Ricardo Torgal, and Cristina Fonseca, all of whom have strong backgrounds in tech and venture capital. They favor founders who demonstrate resilience and ambition, and startups are encouraged to approach them with a clear focus on scalability. Indico’s strategic focus is on sustainable, high-impact innovations, with a particular interest in companies contributing to marine ecosystem health and climate tech.

IndieBio, founded in 2014, is a leading accelerator and venture capital firm focusing on early-stage biotech companies. It operates under SOSV, a global venture capital firm with over $1.5 billion in assets under management. IndieBio provides startups with an initial investment of up to $525,000, followed by continued support throughout subsequent funding rounds, deploying 80% of its capital post-program​. IndieBio has two main locations in San Francisco and New York, supporting a wide range of biotech innovations. Its portfolio includes companies like Upside Foods, NotCo, and Prellis Biologics, which are working on cutting-edge solutions in food tech, AI-driven product development, and 3D bioprinting, respectively. IndieBio emphasizes a diverse and inclusive environment, working with founders from various backgrounds and nationalities. The program is designed to help founders from the earliest stages, including pre-seed and seed, through Series A, by providing access to a robust network of mentors, industry experts, and co-investors​.

Industrifonden, established in 1979 by the Swedish government, is a leading venture capital firm based in Stockholm. With over SEK 5 billion in assets under management, the firm focuses on early-stage investments, typically from seed to A-round funding. Their initial investments range from SEK 10 to 50 million, with the capacity to invest significantly more throughout the lifecycle of their portfolio companies. Industrifonden's investment strategy centers on three main areas: Deep Tech, Life Sciences, and Transformative Technologies. They support innovative startups that address significant societal challenges and have the potential to revolutionize their industries. The firm's evergreen fund structure allows for a long-term focus, fostering sustainable growth and development. Notable portfolio companies include Telness, AnaCardio, Cascade Drives, Asgard Therapeutics, and TrusTrace, reflecting the diversity and impact of their investments. Industrifonden's commitment to long-term value creation and supporting breakthrough innovations makes them a crucial player in the Nordic venture capital landscape.

Industry Ventures, founded in 2000, is a leading venture capital platform with over $8 billion in assets under management. The firm is known for its innovative and flexible approach to investing across the technology growth lifecycle, from early-stage to buyout. Industry Ventures operates through various fund strategies, including primary and secondary investments, tech buyouts, and hybrid funds. The firm recently raised over $1.7 billion across two new funds: Industry Ventures Secondary X, with $1.45 billion, focusing on providing liquidity solutions through direct secondaries and LP interests, and Tech Buyout II, with $260 million, targeting small software company buyouts and emerging software buyout funds. These additions bring the firm's total committed capital to over $7 billion, highlighting its robust presence in the venture capital market. Industry Ventures has a significant track record of successful investments, including companies like Uber, Alibaba, Stripe, Datadog, and Coupang. The firm is headquartered in San Francisco, with additional offices in Washington, DC, and London, ensuring a broad geographic reach to support its portfolio companies and investment strategies effectively.

Inevitable Ventures is a venture capital firm founded in 2015 by billionaire investor Ron Burkle, prominent venture capitalist Chris Hollod, and recording artist and investor D.A. Wallach. The firm focuses on investing in radical emerging technologies that aim to solve complex global challenges and create innovative consumer experiences. Inevitable Ventures has a broad investment scope, with interests in biotechnology, life sciences, e-commerce, financial services, healthcare, software, media, and logistics. The firm’s investment strategy emphasizes identifying and supporting companies that are pioneering transformative technologies with the potential for significant impact and high returns. By leveraging their extensive networks and expertise, the founders of Inevitable Ventures provide not only financial support but also strategic guidance to help their portfolio companies grow and succeed in competitive markets.

Infinity Capital LLC is a venture capital firm headquartered in Palo Alto, California, with a strong focus on investing in early-stage companies across a wide range of industries, including biotechnology, fintech, software, healthcare, and industrial products. Established as a hypothesis-driven investor, Infinity Capital leverages decades of experience in technology and startups, aiming to support groundbreaking innovations that drive change in both business and consumer sectors. The firm actively participates in seed to later-stage funding rounds, often engaging with businesses that show potential for global scalability. Notable portfolio investments include CARD91, Laekna Therapeutics, and Pronto Housing, reflecting their diversified interests in financial services, therapeutics, and housing technology. Infinity Capital is committed to offering strategic capital alongside deep industry insights, with a focus on long-term growth. Their extensive network in Silicon Valley enables them to provide not only financial backing but also operational guidance to entrepreneurs.

Initialized Capital, founded in 2012 by Alexis Ohanian and Garry Tan, is an early-stage venture capital firm based in San Francisco and New York. The firm focuses on seed-stage investments across a wide range of industries, including software, artificial intelligence, healthcare, fintech, sustainability, consumer, and crypto. With over $3.2 billion in assets under management, Initialized Capital has backed more than 200 companies, including 27 unicorns like Coinbase, Instacart, and Flexport. Initialized Capital's unique approach emphasizes investing early, often when companies are valued below $20 million, and providing comprehensive support to founders. This includes assistance in product development, engineering, design, operations, legal, finance, and more. The firm's team comprises experts with diverse backgrounds, ensuring founders receive the guidance they need to navigate the venture landscape​. The firm recently raised $700 million across two new funds: a $530 million core fund for new investments and a $170 million opportunity fund for follow-on investments. This brings their total assets under management to over $3.2 billion, highlighting their significant growth and influence in the venture capital space​.

Inkef Capital, founded in 2010 and based in Amsterdam, is a prominent early-stage venture capital firm focused on technology and healthcare sectors. They prioritize investments in therapeutics, digital health, medical devices, and areas like the Future of Commerce, Future of Work, Data & AI Stack, Fintech, and DeepTech. Inkef is known for their patient, long-term approach, supporting companies from seed to Series A rounds and beyond. Inkef’s portfolio includes notable investments in companies such as GitLab, Onward Medical, and Aidence, reflecting their commitment to impactful, innovative solutions. They have a track record of successful exits, further emphasizing their strategic investment prowess. The firm’s investment strategy revolves around identifying mission-driven entrepreneurs addressing significant global challenges with unique solutions. Inkef prefers companies with ambitious teams ready to scale globally. They value deep, hands-on collaboration, aiming to build lasting companies rather than quick exits​. Key team members include Managing Partner Reitze Douma, Senior Partner Frank Lansink, and Partners like Thijs Cohen Tervaert and Simone Botti. Their diverse and experienced team is dedicated to fostering innovation and supporting founders through various stages of growth. For startups looking to engage with Inkef Capital, demonstrating a clear, innovative vision and readiness for global scale are crucial. They are approachable through their structured process and value long-term strategic partnerships aimed at creating substantial, sustainable impact​.

InMotion Ventures is the venture capital arm of Jaguar Land Rover (JLR), focusing on early-stage investments that align with JLR's strategic goals. Established as a key component of JLR’s Open Innovation programme, InMotion Ventures supports startups from Pre-seed to Series A stages in sectors such as climate tech, industrial technology, and enterprise solutions. Their investments aim to accelerate JLR's Reimagine strategy, which focuses on sustainability and innovation in luxury vehicles and services. The fund offers startups not just capital, but also access to a rich ecosystem of innovators and the broader resources of JLR and Tata Group. This includes partnership opportunities, domain expertise, and significant exposure, helping startups gain a competitive edge and achieve growth. InMotion Ventures' portfolio includes companies like Ascend Elements, which focuses on lithium-ion battery recycling, and ev.energy, which connects electric vehicles to grid networks for greener and more efficient charging. Their investment strategy emphasizes supporting technologies that contribute to a sustainable future.

Innogest Capital, founded in 2005 and based in Turin, Italy, is a prominent venture capital firm with additional offices in Milan, Geneva, and San Francisco. The firm focuses primarily on early-stage investments, particularly in the healthcare and digital sectors. Notable investments include companies like Empatica, Affera, and BetaGlue Technologies. Innogest Capital has a diversified portfolio across several industries. In healthcare, they have invested in companies such as GreenBone, MedLumics, and Newronika, focusing on innovative medical devices, diagnostics, and therapeutic platforms. Their technology investments include digital platforms like MioAssicuratore, Soul-K, and Beintoo, which span online insurance brokerage, food delivery services, and digital marketing solutions. The firm's strategy involves investing between €0.2 million to €2 million in promising startups, helping them scale through hands-on support and leveraging their extensive network. They have made 85 investments to date and have successfully exited from companies like Affera, Everli, and Renovacor. Key team members include Claudio Giuliano, the Co-Founder and CEO, and partners like Giovanni Leo and Franco Rutili, who bring a wealth of experience in venture capital and industry-specific expertise. Innogest Capital is known for its robust support of entrepreneurial visionaries and its commitment to fostering innovation across various sectors, making it a key player in the European venture capital landscape.

Innospark Ventures is a Boston-based venture capital firm founded in 2018 by Dr. Venkat Srinivasan, an AI expert and serial entrepreneur. The firm focuses on early-stage investments, particularly in startups leveraging artificial intelligence to drive innovation across several industries, including healthcare, life sciences, education, cybersecurity, and business services. Innospark is dedicated to backing companies that use AI to tackle significant global challenges. Its portfolio includes notable startups like Marigold Health, which provides AI-driven mental health solutions, and AirWorks, an autonomous aerial mapping platform. The firm typically invests in seed and Series A rounds, supporting startups with funding, mentorship, and strategic insights to help them scale. With a mission to integrate AI into everyday life, Innospark envisions a future where AI enhances human capabilities and addresses pressing problems across sectors. The firm is known for its hands-on approach, helping founders navigate challenges from product development to scaling and exit strategies.

Innova Memphis, founded in 2007 by the Memphis Bioworks Foundation, is an early-stage venture capital firm focused on biosciences, healthcare, technology, and agtech. Based in Memphis, Tennessee, the firm invests in pre-seed, seed, and early-stage startups, aiming to create high-growth companies and jobs in these sectors. The firm has made notable investments in companies like Growers, AgriSync, and Arkis BioSciences. Innova Memphis emphasizes startups with strong intellectual property or competitive advantages. They have raised several funds, including the recent $40 million Innova Ag Innovation Fund VI, which focuses on agtech innovations addressing automation and digitization in agriculture. Innova's team, led by partners Ken Woody, Jan Bouten, and Dean Didato, brings extensive experience in operations, sales, and strategic growth, providing hands-on mentorship and leadership to their portfolio companies. Their approach has attracted over $125 million in outside capital, significantly impacting the local economy by supporting hundreds of jobs​.

InnovaHealth Partners is a private equity firm based in New York City, specializing in growth buyouts of established medical technology companies. Founded in 2016, the firm focuses on the highest growth sectors within the medical device industry, aiming to partner with exceptional management teams to build innovative, differentiated, and high-growth medical technology companies. InnovaHealth Partners manages approximately $290 million of committed capital, which is deployed across the U.S., Europe, and Israel. The firm’s investment strategy is centered on identifying and investing in companies that have the potential to address large unmet medical needs through advanced medical technologies. The team at InnovaHealth brings together over 100 years of combined experience in the medical device sector, having worked together for more than 15 years. The firm’s portfolio includes companies that are leaders in their respective fields, such as Materna Medical, Monteris Medical, and OrthoSpace. These companies are recognized for developing breakthrough technologies in areas like neurosurgery, women’s health, and orthopedic surgery. InnovaHealth Partners takes a hands-on approach to its investments, working closely with portfolio companies to drive growth, enhance operational efficiency, and ultimately improve patient outcomes. This commitment to collaboration and innovation has positioned InnovaHealth as a leading player in the medical device private equity landscape.

EnBW New Ventures (ENV) is the venture capital arm of EnBW, dedicated to investing in early and growth-stage startups that drive the energy transition and sustainability initiatives. Based in Karlsruhe, Germany, ENV has a strong focus on innovative technologies that support decarbonization and digital transformation in energy and related sectors​. ENV's portfolio includes a diverse range of companies, such as Cozero, which offers a comprehensive carbon management software for enterprises; Easelink, known for its Matrix Charging® technology that automates electric vehicle charging; and Intigriti, a global cybersecurity platform connecting companies with ethical hackers​. They also invest in startups like enspired, which automates energy trading, and Holo-Light, which provides augmented reality solutions for industrial applications​. Since its inception, ENV has invested over €125 million across 25 startups, aiming to accelerate the shift to sustainable energy and technologies​ (ENGIE New Ventures)​. The firm’s investments span various geographies and sectors, emphasizing innovations in energy efficiency, renewable energy, energy storage, and smart city solutions. ENV's approach involves not only financial investment but also leveraging EnBW's extensive industry expertise and network to support the growth and scaling of their portfolio companies. This hands-on partnership model has made ENV a significant player in the venture capital space, particularly in the clean energy and sustainability sectors.

Innovation Capital is a €21.1 million venture capital fund based in Sofia, Bulgaria, focused on supporting early-stage startups. The fund primarily invests in pre-seed and seed stages, offering equity and quasi-equity funding to companies across a variety of sectors. Their investment approach is sector-agnostic, covering industries like AI, e-commerce, healthcare, education, fintech, and cybersecurity. Innovation Capital aims to foster high-potential startups that can introduce disruptive innovations and scalable solutions within the local and international markets. The firm has built a diverse portfolio, with more than 100 companies under its belt, including innovative projects like Ubitrack Sport (machine learning for sports analytics) and Kabinet (telemedicine for mental health). They actively seek projects with strong business models and potential for growth, providing investments that range from €25,000 to €1 million depending on the stage of the startup. Innovation Capital also plays a key role in the regional ecosystem by managing accelerator programs, such as XLRadar, which helps early-stage startups refine their business models and gain market traction. The fund receives support from European Structural and Investment Funds, aiming to stimulate competitiveness and economic growth within Bulgaria​.

Innovation Endeavors is an early-stage venture capital firm co-founded by Eric Schmidt, former CEO of Google, and Dror Berman. Headquartered in Silicon Valley, the firm invests in startups driving the "Super Evolution" — a non-linear innovation approach addressing significant global challenges. The firm's investment strategy targets early-stage, seed, and Series A opportunities, typically committing between $1 million and $15 million per initial investment. They focus on supporting technical founders tackling complex engineering and scientific problems to revolutionize large industries. Key areas of focus include intelligent software, computing infrastructure, climate solutions, the physical economy, and engineering health. Innovation Endeavors is deeply involved with its portfolio companies, often taking board seats and leading or co-leading investment rounds. Notable investments include companies like Planet, AlphaSense, Afresh, and Gatik. The firm leverages its extensive networks in technology, academia, and venture capital to provide unparalleled support and opportunities for its community of entrepreneurs. Their mission is to incubate small teams with big ideas, helping them find the right team and partners to achieve their vision.

Innovation Industries is a leading European venture capital firm focused on deep tech investments. With approximately €850 million in assets under management, they specialize in sectors such as industrial tech, med tech, and food & agri tech. The firm targets high-growth potential companies that offer sustainable solutions and have a significant societal impact. Innovation Industries supports companies throughout their growth journey, from early-stage funding to scaling up. They can invest up to €50 million per company over multiple funding rounds, ensuring robust financial backing and strategic guidance. Their portfolio includes cutting-edge companies like Nearfield Instruments, Axelera AI, and Pharrowtech. The team at Innovation Industries brings diverse expertise in fields like physics, engineering, and biotechnology, providing a strong foundation to identify and nurture groundbreaking technologies. Their commitment to sustainability and responsible investment is evident in their rigorous environmental, social, and governance (ESG) criteria. Overall, Innovation Industries is dedicated to driving technological advancements that address fundamental challenges, aiming to create long-term value for both their investors and society at large.

InnovationQuarter is the economic development agency for the Province of Zuid-Holland, focusing on enhancing the region’s economic structure through innovation. The agency is committed to supporting startups and scale-ups, particularly in sectors like high-tech systems, life sciences, energy, and the circular economy. InnovationQuarter offers various investment funds. InnovationQuarter Capital provides up to €5 million for innovative startups and scale-ups with high technological risk, supporting companies with strong management teams and scalable business models. ENERGIIQ, a €35 million fund, is aimed at commercializing proven energy innovations to reduce CO2 emissions, offering up to €4.3 million in venture capital and emphasizing collaborations with reputable co-investors. UNIIQ, a €47 million seed fund, focuses on the proof-of-concept phase, providing up to €350,000 in risk capital for the technical and market validation of innovations. Additionally, InnovationQuarter plays a significant role in internationalization, assisting Dutch businesses in expanding abroad and supporting foreign companies in establishing a presence in Zuid-Holland. The agency collaborates with various stakeholders, including major corporations, SMEs, educational institutions, and government organizations, to foster a dynamic and innovative ecosystem.

Innovestor Group is a prominent Nordic venture capital firm headquartered in Helsinki, Finland. Founded in 2014, it is one of the most active early-stage investors in the region, managing over €250 million across multiple funds. Innovestor focuses on sectors like life sciences, industrial technology, and digital health, with a particular emphasis on sustainable and scalable innovations. The firm is known for being the "first VC check" for many startups, supporting them from pre-seed through to Series A, primarily across the Nordics and Baltics. The firm operates through a combination of direct investments and co-investment syndication, making it a versatile player in the venture capital ecosystem. Innovestor’s portfolio includes nearly 100 high-growth companies, reflecting a diversified approach across sectors such as biotech, clean energy, and industrial automation. Recent initiatives include a €30 million Industry 4.0 fund aimed at fostering industrial tech advancements, and a dedicated €90 million Life Science & Health fund to support breakthroughs in biotech and healthcare. Innovestor distinguishes itself by not only providing capital but also facilitating collaborations between startups and large corporations, as seen through its accelerator programs like the PALO Accelerator. This approach helps startups scale efficiently by tapping into strategic partnerships and industry expertise. With offices throughout the region, Innovestor continues to drive the growth of Nordic+ startups by enabling them to scale internationally.

Inovia Capital, founded in 2007 by Chris Arsenault and others, is a venture capital firm based in Montreal with a significant presence in the Canadian tech ecosystem. The firm manages over $2.5 billion in assets across multiple funds, including early-stage venture and growth funds. Inovia focuses on partnering with founders to build impactful and enduring global companies, offering support from seed to IPO and beyond​. Notable investments in their portfolio include Lightspeed Commerce, AppDirect, Sonder, and Hopper. Inovia has achieved several successful exits, such as the IPOs of Lightspeed and Sonder, and acquisitions like Luxury Retreats by Airbnb and Well.ca by McKesson​. The firm's strategy emphasizes a hands-on approach, leveraging its team of experienced investors and operators to provide strategic guidance, mentorship, and access to a global network

Insight Partners, founded in 1995 and headquartered in New York City, is a global venture capital and private equity firm renowned for investing in high-growth technology, software, and internet companies. The firm has a vast portfolio of over 1,600 investments, including notable companies like Calm, monday.com, WalkMe, and Checkout.com​. The firm is particularly known for its significant investments across various sectors such as IT infrastructure, cybersecurity, fintech, e-commerce, and DevOps. In 2022, Insight Partners closed its largest fund to date, raising over $20 billion, which underscored its aggressive investment strategy and commitment to high-growth companies​​. Insight Partners employs a hands-on approach to supporting its portfolio companies, offering extensive resources through its Onsite team. This team comprises over 130 experts in areas like sales, marketing, product development, and talent acquisition, dedicated to helping companies scale efficiently. This support has been crucial in helping many of their portfolio companies achieve significant growth and successful exits​. Overall, Insight Partners' combination of substantial financial resources, strategic support, and industry expertise positions it as a leading player in the global venture capital landscape​.

Intel Capital, based in Santa Clara, California, is a leading venture capital firm and the investment arm of Intel Corporation. With a robust portfolio featuring 24 unicorns like Figure and AI21 Labs, Intel Capital has cemented its position in the tech industry. Their investments span across AI, cloud, cybersecurity, and semiconductor sectors, targeting companies that are pushing the boundaries of innovation. Notable investments include SecurityScorecard, DataRobot, and Syntiant. Intel Capital's global reach is significant, with investments in over 1,500 companies across 57 countries. They are stage-agnostic, typically investing from seed to growth stages, with check sizes varying according to the company’s needs. Their strategy involves not just funding but also providing strategic guidance and access to Intel’s extensive network of partners and customers, fostering rapid growth and market entry. The firm has a track record of successful exits, with 35 portfolio companies going public, such as ZEEKR and Astera Labs. Intel Capital also prioritizes diversity, having launched a $125 million fund dedicated to businesses led by women and underrepresented minorities. Intel Capital is led by experienced professionals like Wendell Brooks, who have deep expertise in technology and investment. They encourage startups to approach them through their well-defined programs, offering a blend of financial support and strategic advice to drive innovation and growth in the tech ecosystem.

Intermountain Ventures is the strategic venture capital and innovation arm of Intermountain Health, one of the largest not-for-profit healthcare systems in the western United States, headquartered in Salt Lake City, Utah. Founded in 2012, the firm invests in transformational early- and growth-stage companies aimed at improving healthcare delivery, operations, patient experience, and clinical outcomes. Managing Partner Nickolas Mark leads a team of nine, including three partners, deploying $1 to $5 million per company across Series A, B, and C rounds. Six primary investment focus areas structure the portfolio: Enterprise Enablement, Care Site Optimization, Workforce Transformation, Consumer Experience, Clinical Advancement, and Proactive Care. As of January 2026, Intermountain Ventures has invested in 27 companies with an exceptional exit record. The portfolio includes 2 unicorns in Freenome Health and Olive, and 3 IPOs: Omada Health on NASDAQ in June 2025 at a $1.06 billion market cap and Recursion Pharmaceuticals on NASDAQ at a $2.92 billion market cap. Ten acquisitions have been completed, including Armis, which was acquired by ServiceNow in December 2025 for $7.75 billion — a cybersecurity outlier that represents one of the largest outcomes from a healthcare-focused CVC portfolio. The most recent investment was knownwell at Series B in October 2025, with four total investments made in 2025. Intermountain Ventures provides portfolio companies with clinical expertise, de-identified data access, and integration opportunities within the Intermountain Health system, creating a meaningful channel for real-world validation that pure financial investors cannot match. The firm co-invests with other health system venture arms including Triventures, Health Enterprise Partners, and Ascension Ventures. Intermountain Health has also joined Microsoft, Gates Ventures, Epic, and West Health in an initiative to address healthcare access challenges in rural America.

InterWest Partners, established in 1979, is a venture capital firm focused on early-stage investments in the information technology and healthcare sectors. Based in Menlo Park, California, the firm has raised over $2.8 billion across ten funds. Throughout its history, InterWest has backed more than 250 companies, achieving 97 IPOs and participating in 95 acquisitions. InterWest Partners IX, one of their notable funds, closed at $606 million and primarily invests in early-stage companies within its targeted sectors. The firm is known for its successful investments in companies such as Doximity, Canva, Braze, and Glaukos. InterWest's approach focuses on partnering with world-class entrepreneurs to build leading companies in IT and healthcare, supporting them through various growth stages. While InterWest Partners is not currently seeking new investments, their legacy includes influential early wins in companies like Xilinx and CIENA in the IT sector, and COR Therapeutics and Ventritex in healthcare, cementing their reputation as a key player in the venture capital landscape.

Intudo Ventures, founded in 2017 by Patrick Yip and Eddy Chan, is a pioneering venture capital firm that exclusively invests in Indonesian startups. With a concentrated portfolio approach, Intudo focuses on sectors like agriculture, B2B & enterprise, education, finance, healthcare, and logistics. The firm typically invests between $1 million and $10 million, primarily in early-stage and Series A rounds, but also participates in Series B and C rounds for its established portfolio companies. Intudo has built a reputation for backing high-potential companies such as Pintu, TaniHub, and Gredu. Their strategy leverages the expertise of returnee Indonesians who have gained experience and networks abroad, particularly from the U.S. This approach is bolstered by programs like the Pulkam S.E.A. Turtle Fellowship, which helps integrate returning talent into Indonesia's tech ecosystem. The firm’s deep local involvement allows them to maintain close relationships with their portfolio companies, providing significant support beyond just capital. Intudo ensures every investment is strategically aligned with Indonesia's regulatory environment and market dynamics, giving their companies a competitive edge. Key team members include co-founders Eddy Chan and Patrick Yip, who bring extensive experience in venture capital and entrepreneurial ventures across Silicon Valley and Asia. Intudo Ventures is headquartered in Jakarta, Indonesia, and continues to champion the growth of the local digital economy through its targeted investment strategy and hands-on approach.

Inventages Venture Capital, founded in 2000 by Gunnar Weikert, is the venture capital arm of Nestlé, headquartered in Nassau, Bahamas. The firm specializes in health care, life sciences, pharmaceuticals, cosmeceuticals, enabling technologies, and medical devices. Inventages has a broad investment focus, participating in seed, early, mid, and late-stage ventures. Notable investments include Accera, a biotechnology firm focused on therapies for neurodegenerative diseases, and Phagenesis, which develops treatments for dysphagia. Other significant investments are Shield Therapeutics, known for its iron deficiency treatments, and Cognoptix, which is developing diagnostics for Alzheimer's disease​. Inventages typically invests with an average round size of $14 million, demonstrating a strong commitment to substantial funding rounds. The firm is actively involved in guiding its portfolio companies through strategic growth and development stages. Key team members include Gunnar Weikert (Founder and CEO), Thomas Bayerl, and Wolfgang Reichenberger, all bringing significant expertise in venture capital and life sciences to the table. Inventages is particularly noted for its rigorous due diligence process and a strong focus on the commercial viability of scientific innovations. This approach has enabled them to support groundbreaking developments in health and wellness sectors​.

Inventure is a venture capital firm founded in 2005, headquartered in Helsinki, Finland, with a focus on early-stage investments across the Nordic and Baltic regions. The firm supports innovative startups in sectors ranging from deep tech to consumer internet brands. Inventure’s investment strategy centers around being the first institutional investor in most of its portfolio companies, providing capital and guidance to help them scale. The firm is known for backing over 90 companies, including notable successes like Wolt, Swappie, and Stravito. With ticket sizes ranging from €300,000 to €5 million, Inventure has raised significant capital across multiple funds, the latest announced in 2022. This enables the firm to provide critical early-stage funding to founders tackling unique challenges in their respective regions. Inventure operates as a generalist fund but with strong conviction in the teams it backs, emphasizing the importance of supporting ambitious founders. The firm’s hands-on approach helps startups overcome early-stage hurdles, offering both financial support and strategic resources. Through its offices in Helsinki and Stockholm, Inventure has built a robust network across the Nordic and Baltic startup ecosystem, making it a key player in the region’s venture capital landscape. In addition to its financial investments, Inventure also assists portfolio companies with talent acquisition, product development, and international expansion, ensuring they have the tools necessary for long-term success.

Inveready, founded in 2008 and headquartered in Barcelona, is a prominent asset manager in Spain, specializing in various stages of venture capital, growth capital, venture debt, strategic public equity, private equity, and infrastructure investments. With over €1.2 billion in assets under management and a portfolio of 220 companies, Inveready has a strong track record of supporting innovative and high-growth ventures. The firm’s investment strategies span multiple sectors, including technology, biotech, fintech, medtech, and industrial technologies. Notable portfolio companies include Feedzai, which has achieved unicorn status, and several others that have been acquired by major multinationals such as Intel, Symantec, and Facebook, or have listed on major stock exchanges like Nasdaq and Euronext. Inveready typically invests between €500,000 and €5 million, supporting companies from early stages to growth and beyond. They have offices in San Sebastián, Madrid, and Barcelona, positioning them well to leverage opportunities across Europe and North America. Their unique approach combines traditional equity investments with innovative financing solutions like venture debt and tax lease structures, tailored to minimize dilution for founders while maximizing growth potential.

Invesco Private Capital, a division of Invesco, specializes in a broad range of investments, including early-stage ventures, growth capital, buyouts, and private equity. With over 25 years of experience, they leverage a deep network of industry relationships and extensive market insights to identify and support high-potential startups and emerging private equity managers​. Invesco’s notable investments span across various sectors, including technology, healthcare, and financial services. They have been involved in significant ventures and direct investments that align with their strategy of partnering with innovative and scalable companies. Their comprehensive approach includes not only capital investment but also strategic support and operational expertise to help portfolio companies achieve sustainable growth. For more information on their investment strategies and portfolio, you can visit the Invesco website or explore their detailed profiles on investment platforms like PitchBook and Crunchbase.

Invest-NL is a Dutch impact investment firm dedicated to financing innovative projects and companies that drive sustainability and innovation in the Netherlands. The firm, established in 2020, focuses on supporting entrepreneurs with substantial plans for a sustainable future. Their mission is to enable projects that may otherwise seem unfinanceable, contributing to major societal transitions such as the shift to a carbon-neutral and circular economy. Invest-NL's investment activities span various sectors, including deep tech, life sciences, energy transition, and agrifood. Notable initiatives include the Dutch Future Fund, which mobilizes up to €1.5 billion for innovative SMEs, focusing on energy transition and sustainability. One of Invest-NL's significant investments is in Regeneration.VC Fund II, a venture capital fund aimed at consumer climate tech. This €5 million investment helps bridge Dutch startups with the U.S. market, providing them with access to American multinationals and capital markets. Invest-NL collaborates with the European Investment Fund (EIF) and the Dutch Ministry of Economic Affairs and Climate to support high-potential ventures, making impactful contributions to both the Dutch economy and global sustainability efforts.

Investec, an Anglo-South African international banking and wealth management group, is recognized for its diverse investments and notable projects. The company operates globally, offering financial products and services to clients in Europe, Southern Africa, and the Asia-Pacific region. It is dual-listed on the London and Johannesburg Stock Exchanges. One of Investec's significant projects is its partnership with Proparco on the Transforming Financial Systems for Climate (TFSC) program. This initiative supports South Africa's transition to a low-carbon economy with an $80 million climate finance-dedicated credit facility aimed at expanding climate-related financing in the region. This project aligns with South Africa's goal to reduce carbon emissions by 42% by 2025 and diversify its electricity production away from coal by 2050. Investec has also been instrumental in financing renewable energy projects, such as the €72.5 million facility for WElink's 220MW Solara4 solar PV farm in Portugal, Europe's largest unsubsidized solar project. This project will provide sustainable energy to 200,000 homes and reduce carbon emissions significantly. Moreover, Investec's energy and infrastructure finance division has arranged over $11 billion in financing in North America over the past three years, demonstrating its expertise in conventional and renewable power, midstream oil and gas, transportation, and digital infrastructure. These initiatives highlight Investec's commitment to sustainability and its strategic focus on supporting large-scale renewable projects and climate-related investments globally.

Investible is a prominent early-stage venture capital firm based in Sydney and Singapore, focusing on investments in Australia, New Zealand, Southeast Asia, and globally. Established to support visionary founders, Investible targets pre-seed to Series A companies across various sectors, including fintech, martech, edtech, healthtech, and climate tech. The firm operates through several funds, including the $51.6 million Early-Stage Fund 2 and the Climate Tech Fund. They also have a unique investment syndicate called Club Investible, which includes over 150 members who invest alongside the firm's funds. This model allows Investible to offer comprehensive support, including capital, expertise, and an extensive network of advisors and industry connections. Investible's portfolio includes notable companies like Quantum Brilliance and Manetta's Seafood Market, highlighting their diverse investment strategy. They emphasize a founder-friendly approach, aiming to provide ongoing support as businesses grow, with check sizes typically ranging from AU$250,000 to AU$1.5 million.

IP Group is a leading FTSE-250 listed venture capital firm specializing in intellectual property commercialization. Notable for its deeptech focus, IP Group has been instrumental in developing over 300 companies, with significant investments in life sciences, cleantech, and cutting-edge technologies. High-profile portfolio companies include Oxford Nanopore Technologies, Centessa Pharmaceuticals, and Hinge Health. Geographically, IP Group maintains a strong presence in the UK, with partnerships across 17 UK universities and significant ties to institutions in the US, Australia, and New Zealand. The firm’s investment strategy emphasizes patient capital and long-term support, particularly in university spin-outs. IP Group invests at various stages, from seed to growth, and often continues funding as companies scale. This approach includes providing commercialization assistance, executive recruitment, and securing growth-stage capital from co-investors. The firm’s evergreen structure allows it to sustain the lengthy development cycles typical of deeptech ventures. Key team members include CEO Greg Smith and COO Alan Aubrey, who bring extensive expertise in technology transfer and IP management. IP Group typically leads investment rounds and prefers to be approached by startups with strong IP and technological differentiation. With an average check size of over £1.5m for VC rounds, the firm remains highly active, having invested £1bn in the first half of the current financial year. In summary, IP Group’s robust support system, extensive university partnerships, and strategic patience make it a cornerstone for deeptech and innovative startups looking to transform breakthrough ideas into commercial realities.

IQ Capital is a leading venture capital firm based in Cambridge, UK, specializing in deep tech investments. With over $1 billion in assets under management, IQ Capital targets seed to Series A stage startups across the UK and Europe, focusing on transformative technologies like AI, quantum computing, robotics, and synthetic biology. Notable investments include Grapeshot (acquired by Oracle), Bloomsbury AI (acquired by Facebook), and Thought Machine, a prominent cloud banking startup valued at $2.7 billion. IQ Capital's strategy emphasizes investing in IP-rich technologies with global market potential. Initial investments range from $2.5 million to $5 million, with follow-on investments reaching up to $15 million. The firm recently closed its fourth venture fund at $200 million to support deep tech companies from seed through growth stages. Key team members include co-founders Max Bautin and Kerry Baldwin, both with extensive experience in deep tech venture capital. The team has grown significantly, adding experts like Rick Hao and Daniel Carew, who bring diverse expertise across AI, cybersecurity, and advanced manufacturing.

IRIS Ventures is a growth equity firm focused on supporting visionary founders building consumer brands that prioritize health, wellness, and convenience. Launched in 2021, IRIS operates across Europe, the UK, and the US, investing in tech-enabled solutions that aim to make life healthier and more sustainable. The firm champions companies that embrace responsible innovation, transparency, and diversity, with a particular emphasis on long-term societal impact. Key brands in the IRIS Ventures portfolio include Saysh, the women’s athletic footwear company founded by Olympic athlete Allyson Felix; Artemest, a luxury marketplace that showcases Italian craftsmanship; and Vicio, a rapidly growing food delivery startup in Spain. Other investments, like Biomel, which offers plant-based gut health products, and Olistic, a wellness brand focused on hair care, reflect IRIS’s commitment to well-being and modern consumer needs. The firm’s investment approach is centered around empowering brands that resonate with today's consumers, helping them scale while fostering positive change. IRIS Ventures seeks out companies at the intersection of health, sustainability, and convenience, focusing on those that can drive both economic returns and social impact. Their mission is to back founders who are rewriting the future of consumer goods, with a strong belief that brands should not only deliver exceptional products but also contribute to a more inclusive and healthier world​.

IrishAngels is an angel investing network associated with the University of Notre Dame, focusing on pre-seed and seed stage startups. With a network of over 250 investors, IrishAngels has deployed more than $20 million in capital across various sectors including B2B, consumer, and medical companies. They provide substantial support through their active network, ensuring that companies receive not only financial backing but also strategic guidance and resources for growth. Notable investments in their portfolio include Elevate K-12, a platform providing live streaming online instruction; Genomenon, which offers a comprehensive source of genomic evidence; and Hallow, a Christian prayer app that provides guided religious content. They also have investments in technology-driven companies like Groupsense, which tracks cyber threats, and Fulcrum, which powers a connected manufacturing supply chain through machine learning. IrishAngels holds quarterly meetings, currently conducted remotely, providing investors with opportunities for networking and business development. The group emphasizes a collaborative and founder-friendly approach, maintaining regular check-ins to support portfolio companies.